Clinical Trial Update: Treatment of Patients With Atherosclerotic Disease With Methotrexate-associated to LDL Like Nanoparticles [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on methotrexate-associated LDL-like nanoparticles for atherosclerotic disease, covering Phase 2 and Phase 3 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Inflammation

Drugs mentioned

• Methotrexate-associated LDL-like nanoparticles

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Atherosclerosis, Coronary Artery Disease | Phase 2, Phase 3 | Status: UNKNOWN